DUBLIN, March 2, 2023 /PRNewswire/ -- The "Growth Opportunities In Gene Editing Technologies, Advanced RNA Therapeutics, Antibody Drug Conjugates and Biomanufacturing" report has been added to
ResearchAndMarkets.com's offering.
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) highlights some of the recent innovations in gene editing technologies, which aim to make them more targeted and efficient. It also covers few innovations around ADCs (antibody drug conjugates) and its different components which are paving the way for development of safer and longer acting ADCs. In addition, advances in RNA therapeutics including small activating RNA and circular RNA based therapeutics and targeted delivery carriers have been covered. A PoC diagnostic to diagnose psoriasis and automation platform for egg and embryo management are also a part of this issue. The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.
The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Innovations in Gene Editing Technologies, Advanced RNA Therapeutics, Antibody Drug Conjugates and Biomanufacturing
Exploring the Potential of Circular Ribonucleic Acid (RNA) Therapeutics To Treat Rare Diseases
Accelerated Clinical Development of Small Active RNAs to Treat Difficult to Target Diseases
Artificial Intelligence (AI)-based Platform Developing Biocompatible RNA Delivery System to Target Multiple Organs
Value Proposition of Sixfold Bioscience
Engineered Ribonucleoprotein (RNP) for Delivery of Gene Editing Molecule
Advanced Analytical Tools to for Cell Line Optimization and Development
Valitacell-Value Proposition
ValitaCell-Investor Dashboard
AI Powered, Integrated Supply Chain Management Platform for Cell and Gene Therapies
Trakcel-Investor Dashboard
Novel Class of Site-Specific Nuclease for Development of Allogeneic CAR-T Cells Synthetic Enzyme based on Meganucleases For Developing Innovative Therapies
Value Proposition of Precision Biosciences,
RNA Interference & TCR Inhibition technology for Generating Allogeneic CAR-T Cells Value Proposition of Celyad Oncology
Celyad Oncology-Investor Dashboard
Targeted Gene-editing Technology Using Short Guide RNA for the Development of Transformative Medicines
Value Proposition of Editas Medicine
Engineered Zinc Finger Nuclease Based Targeted Gene Editing
Therapeutics Targeting Growth Factor Pathways to Treat Fibrotic Indications Microfluidics-based Platform for Differential Diagnosis of Psoriasis and Eczema Dermagnostix GmbH-Value Proposition
Dermagnostix-Investor Dashboard
Toolbox Approach to Developing ADC Technologies for Various Types of Oncologic Targets Plug-and-play Engineered Antibodies for Targeted Cancer and Viral Disease Therapeutics Streamlined and Automated Cryospecimen Management Platform for Frozen Eggs and Embryos for Infertility Treatment
Digital Biomarkers for Drug Development Trials in the Pharmaceutical Industry
VivoSense's Value Proposition
VivoSense-Investor Dashboard
Flexible, Scalable and Cost-efficient Peptide Based Linker Platform, Offering Highly Stable Antibody Drug Conjugates
Criteria for Rating of Innovations--Explanation
A selection of companies mentioned in this report includes
For more information about this report visit https://www.researchandmarkets.com/r/adr4w2
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets